Dr. Eli Shalom
CEO & Co- Founder
An experienced radiopharmacist. Prior to founding Isotopia he was involved for eight years in the research and development and production of SPECT and PET isotopes in the National Nuclear Research Center at Nahal Soreq. With a Ph.D degree from the Hebrew University (Jerusalem) in the Synthesis of Novel Amine [18F] Fluorocyanoboranes & Amine [18F] Fluorocarboxyborane Esters, Dr. Shalom is regarded as one of the leading professionals in this sector in Israel. He is well known as a knowledgeable researcher with practical applications in product development of radio-isotopes including SPECT & PET tracers. Dr. Shalom has a registered patent in this field as well as many publications in the professional literature.
Director of Business Development
Joined isotopia from the Foundation in 2007 as the company’s customer service and support. keren has taken on very quickly the sales and marketing division and managed the department for the last six years, during which she launched the unique diagnostic product Ga-68 PSMA and approve it for reimbursement by MOH.
Currently manages the business development department and a student at Tel Aviv University studying Health System Director. The first product launched under the Business Development Lu177-PSMA as a unique and innovative therapy for the treatment of prostate cancer.
Keren’s focus is to identify trends and opportunities in nuclear medicine, to bring new technologies and promote collaboration with global manufacturers.
Eyal Gimshi, M.Sc
Head of theray unit
Eyal Gimshi joined Isotopia from the company onset, initially as an accelerator operator on a part-time basis, while studying towards his bachelor degree in Nuclear Engineering. Subsequently Eyal became a full-timer and completed his master’s degree in Nuclear Engineering from Ben Gurion University, his thesis on a research project using the cyclotron in Isotopia. In his role as Chief Operating Officer Eyal has successfully steered the corporate operation to a highly efficient and advanced radiopharmaceutical producer.
Eyal holds a MBA in technology management, is happily married and a father of 2 beautiful daughters.
Industrial pharmacist with 35 years of experience in the pharmaceutical, radio pharmaceutical and chemical industries.
Major fields of experience:
Development and scale up of production processes.
Automatization of production processes for radio-tracers and radionuclides.
Trouble shooting of production processes.
Conceptual design of pharmaceutical production facilities.
Conceptual design of process equipment.
Establishment of QA systems in accordance with ICH-Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (API).
Preparation of Drug Master file for API’s.
Head of Sterile plant
With over 10 years practice managing complex operation units in global competitive environment, Tzachi joined Isotopia to lead the aseptic site. Tzachi holds a Bsc. in Industrial Engineering with MBA, and PMP Certified, and has proven track record in establishment of lean operational structures, processes and systems. He is Strong Change leader in key areas of Logistics, Manufacturing, Supply Chain, Finance, Engineering, Quality Assurance and Compliance. Tzachi is happily married and father of 3 energetic sons.
As the Company’s Chief Financial Officer Matan heads the Accounting & Finance related endeavors.
Matan brings rich experience that includes all aspects of accounting, budgeting, fundraising, capital allocation, M&A transactions, reporting, business planning and strategy and cash flow management.
Prior to joining Isotopia, Matan served first as the financial controller and later as the CFO of Hutchison Kinrot Incubator and its portfolio companies.
He previously worked as an Assistant Financial Controller at TowerJazz Semiconductor, a publicly listed manufacturer (NASDAQ & TASE) of analog integrated circuits.
Also in the assurance services department of Ernst & Young, was FP&A analyst at Lumenis (a medical equipment company), and served as a consultant and economist at a consulting company which provides a full range of business development expertise.
Matan holds a B.A in Economics and Business Administration from Haifa University and graduated from the Accounting Studies program at Bar Ilan University. He is a certified CPA.
Dr. Haim Golan
Dr. Golan was the Director of Nuclear Medicine at Assaf Harofeh Medical Center, Israel. Currently he is the chief medical officer at “Isotopia molecular imaging”. He is one of Israel’s leading Nuclear Medicine physicians, having presented at numerous seminars, written scores of abstracts and publications.
Dr. Golan received his MD from Ben-Gurion University. He trained in Nuclear Medicine at Soroka Medical Center and has been practicing Nuclear Medicine since 1989.
Especially noteworthy is Dr. Golan’s strong scientific background. In addition to his MD Dr. Golan holds B.Sc and M.Sc degrees in Radiobiology from the Biology Department at Ben Gurion University.
Dr. Golan has done extensive research in the fields of nuclear brain imaging both in Israel and abroad as a Clinical Fellow in the department of medical Imaging, University of Toronto, Canada, in the division of Nuclear Medicine, Mount Sinai Hospital and in the division of Nuclear Medicine, Sick Children Hospital.
Dr. Golan harbors a special interest in brain SPECT and PET imaging, he utilizes his expertise in this area, as one of only a handful such experts throughout Israel who perform the cutting edge scans on a variety of patients including patients suffering from Parkinson’s disease.
Dr. Shimon Farber
Quality Control Manager of Sterlie plant
Dr. Shimon Farber joined Isotopia after 8 years of Quality Control Management, including Chemistry, Microbiology, Radioactive and Radio pharmacy laboratories. Shimon holds a Ph.D. degree from the Hebrew University of Jerusalem in the field of “Conjugation of polysaccharides with toxic API’s” followed by Post doctorate in “Orally available docetaxel nanotransporter formulation” research. Dr. Shimon is experienced in managing various Quality Control aspects starting from raw materials entrance to final product release including shelf life and stability evaluations. In addition, Shimon’s responsible for product validations and new Contract manufacturing products implementation in the QC laboratories. As the QC Manager Dr. Shimon had a leading role through the successful regulatory audits of Israeli Ministry of Health, Dutch Health Care Inspectorate (IGZ) and FDA. Shimon is happily married and has 3 children.
New Product & COM Manager of Sterlie plant
Mor is the New Product development and Contract Manufacturing Manager, Isotopia Molecular Imaging Ltd. Responsible for Technology Transfer of new products from R&D to commercial manufacturing, site leader of the Contract Manufacturing activities. In the past 10 years Mor worked in the Pharma industry in various Quality positions, managing challenging sub-contracting project. Mor has extensive experience in GMP manufacturing processes of Sterile and Aseptic products, standards and procedures. Mor holds B.Sc. degree in Chemistry and Biotechnology Engineering from Ariel University, Israel.
Engineering & Maintenance Activities Manager of Sterlie plant
Vladimir joined Isotopia early 2019 to lead the engineering and maintenance activities. Vladimir has 25 years of experience in the semiconductors and pharmaceutical industry in different areas of operations and management including Plant engineering, Maintenance and Project management. Specializes in electricity, instrumentation, system control, calibration and water systems – HPW\WFI & OFA & HVAC system. Sterile filling, lyophilization and autoclave equipment, Utilities improvement & System Validation.